Jazz Pharmaceuticals PLC (JAZZ) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 5, 2026.

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free
Filings shown
30
Open-market buys
0
Open-market sells
12

Counts cover the 30 most recent Form 4 filings Tradune holds for JAZZ (filed Jul 6 – Oct 5, 2026); the score below covers only the trailing 90 days (0 buys, 11 sells). No completed check of JAZZ's Form 4 list on SEC EDGAR is on record yet; the latest JAZZ filing Tradune holds was filed Oct 5, 2026. This is not guaranteed to be the complete record — see JAZZ's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 29 filings Tradune holds for JAZZ filed Aug 5 – Oct 5, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

11 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
11 sales· 98,121 sh
checkbox disclosed
On filings with the box not checked
0 sales· 0 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Robert IannoneEVP, Global Head of R&D & CMO 0 6 — 76,921 −$19,207,098
Bruce C. CozaddDirector 0 3 — 18,000 −$4,400,640
Renee D. GalaPresident & CEO 0 1 — 2,000 −$486,060
Neena M. PatilEVP & Chief Legal Officer 0 1 — 1,200 −$289,128

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score
0/ 100
Net insider sales
0 distinct buyers0 buy · 11 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at JAZZ

No open-market insider purchases (Form 4 code P) were reported for JAZZ between Jul 6, 2026 and Oct 5, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Bruce C. Cozadd Director · filed Oct 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 6,000 $230.33 345,875 −1.7% Oct 1, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Neena M. Patil EVP & Chief Legal Officer · filed Sep 14, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 1,200 $240.94 47,671 −2.5% Sep 10, 2026
Mary Elizabeth Henderson SVP, Technical Operations · filed Sep 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 15 $241.20 23,815 −0.1% Sep 8, 2026
Tax withholding 1,412 $243.03 23,830 −5.6% Sep 8, 2026
Renee D. Gala President & CEO · filed Sep 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 1,967 $246.81 145,394 −1.3% Sep 8, 2026
Open-market sale 10b5-1 box checked 2,000 $243.03 143,394 −1.4% Sep 8, 2026
Bruce C. Cozadd Director · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 6,000 $250.13 351,875 −1.7% Sep 1, 2026
Tax withholding 10 $244.06 359,084 −0.0% Aug 31, 2026
Tax withholding 1,209 $241.39 357,875 −0.3% Aug 31, 2026
Patrick Kennedy Director · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 15 $244.06 8,292 −0.2% Aug 31, 2026
Tax withholding 1,840 $241.39 6,452 −22% Aug 31, 2026
Mary Elizabeth Henderson SVP, Technical Operations · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 2,076 $241.39 25,258 −7.6% Aug 31, 2026
Tax withholding 16 $244.64 25,242 −0.1% Aug 31, 2026
Mark Douglas Smith Director · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 14 $244.64 11,271 −0.1% Aug 31, 2026
Tax withholding 1,692 $241.39 9,579 −15% Aug 31, 2026
Jennifer E. Cook Director · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 14 $244.06 12,428 −0.1% Aug 31, 2026
Tax withholding 1,692 $241.39 10,736 −14% Aug 31, 2026
Laura Hamill Director · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 14 $244.06 8,524 −0.2% Aug 31, 2026
Tax withholding 1,692 $241.39 6,832 −20% Aug 31, 2026
Heather Ann McSharry Director · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 15 $244.64 20,039 −0.1% Aug 31, 2026
Tax withholding 1,840 $241.39 18,199 −9.2% Aug 31, 2026
Rick E. Winningham Director · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 1,692 $241.39 9,480 −15% Aug 31, 2026
Tax withholding 14 $244.64 9,466 −0.1% Aug 31, 2026
Patrick G. Enright Director · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 14 $244.64 22,970 −0.1% Aug 31, 2026
Tax withholding 1,692 $241.39 21,278 −7.4% Aug 31, 2026
Ted W. Love Director · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 6 $244.06 3,126 −0.2% Aug 31, 2026
Tax withholding 737 $241.39 2,389 −24% Aug 31, 2026
Norbert G. Riedel Director · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 14 $244.64 8,615 −0.2% Aug 31, 2026
Tax withholding 1,692 $241.39 6,923 −20% Aug 31, 2026
Robert Iannone EVP, Global Head of R&D & CMO · filed Aug 31, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 884 $113.10 112,107 +0.8% Aug 27, 2026
Option exercise 27,584 $137.12 139,691 +25% Aug 27, 2026
Option exercise 2,916 $137.12 142,607 +2.1% Aug 27, 2026
Open-market sale 10b5-1 box checked 18,187 $247.86 124,420 −13% Aug 27, 2026
Open-market sale 10b5-1 box checked 11,423 $248.67 112,997 −9.2% Aug 27, 2026
Open-market sale 10b5-1 box checked 18,113 $250.02 94,884 −16% Aug 27, 2026
Open-market sale 10b5-1 box checked 19,639 $250.60 75,245 −21% Aug 27, 2026
Open-market sale 10b5-1 box checked 9,259 $251.95 65,986 −12% Aug 27, 2026
Open-market sale 10b5-1 box checked 300 $252.76 65,686 −0.5% Aug 27, 2026
Option exercise Incentive Stock Option (right to buy) 884 — — — Aug 27, 2026
Option exercise Incentive Stock Option (right to buy) 2,916 — — — Aug 27, 2026
Option exercise 26,116 $113.10 111,223 +31% Aug 27, 2026
Option exercise Non-Qualified Stock Option (right to buy) 26,116 — — — Aug 27, 2026
Option exercise Non-Qualified Stock Option (right to buy) 27,584 — — — Aug 27, 2026
Patrick Kennedy Director · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 1,605 — 8,307 +24% Aug 5, 2026
Samantha Pearce EVP, Chief Commercial Officer · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 780 $261.62 47,131 −1.6% Aug 5, 2026
Mark Douglas Smith Director · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 1,605 — 11,285 +17% Aug 5, 2026
Jennifer E. Cook Director · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 1,605 — 12,442 +15% Aug 5, 2026
Laura Hamill Director · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 1,605 — 8,538 +23% Aug 5, 2026
Heather Ann McSharry Director · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 1,605 — 20,054 +8.7% Aug 5, 2026
Seamus Mulligan Director · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 1,605 — 1,184,633 +0.1% Aug 5, 2026
Rick E. Winningham Director · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 1,605 — 11,172 +17% Aug 5, 2026
Patrick G. Enright Director · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 1,605 — 22,984 +7.5% Aug 5, 2026

Listing the 25 most recent of 30 Form 4 filings held for JAZZ; the 5 older filings (filed Jul 6 – Aug 7, 2026) are counted above but not listed here — see JAZZ's full Form 4 filing history on SEC EDGAR.

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to JAZZ's (Oct 5, 2026).

Frequently asked about JAZZ insider activity

How many insiders bought JAZZ stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of JAZZ shares were reported by Jazz Pharmaceuticals PLC insiders between Jul 6, 2026 and Oct 5, 2026. The 30 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for JAZZ?

The most recent Form 4 on this page was filed by Bruce C. Cozadd (Director) on Oct 5, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market JAZZ insider sale shown?

The largest open-market sale among the filings shown was 19,639 JAZZ shares at $250.60 (about $4,921,596) by Robert Iannone (EVP, Global Head of R&D & CMO) on Aug 27, 2026. Value is shares × the price reported on the Form 4; that Form 4 has the Rule 10b5-1 box checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for JAZZ — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

Track JAZZ insider filings free →

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.